Regeneron hopes for quick FDA decision on high-dose Eylea as Roche’s rival surges kdunleavy Thu, 08/03/2023 – 10:14 More: Regeneron hopes for quick FDA decision on high-dose Eylea as Roche's rival surges Source: fierce
read moreThe candidate is a stroma-degrading oncolytic adenovirus for the treatment of pancreatic cancer More: Theriva Biologics reveals positive VCN-01 study results Source: News
read moreMHRA has made the company a member of the UK GLP compliance monitoring programme More: Metrion Biosciences boosts hERG screening service Source: News
read moreWith Takeda and Hutchmed hot on the trail, Taiho wins FDA nod for stronger Lonsurf regimen in colorectal cancer aliu Wed, 08/02/2023 – 16:07 More: With Takeda and Hutchmed hot on the trail, Taiho wins FDA nod for stronger Lonsurf
read moreBiogen looks at selling biosims unit to longtime ally Samsung Bioepis: reports kdunleavy Wed, 08/02/2023 – 14:51 More: Biogen looks at selling biosims unit to longtime ally Samsung Bioepis: reports Source: fierce
read moreIn ‘advanced’ settlement talks, Teva sets aside $200M to resolve US price-fixing probe fkansteiner Wed, 08/02/2023 – 14:00 More: In 'advanced' settlement talks, Teva sets aside 0M to resolve US price-fixing probe Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals